Prostatype Genomics AB (publ)

STO-PROGEN
Nasdaq Stockholm
Healthcare Diagnostics & Research
Global Rank
#43832
Country Rank
#701
Market Cap
4.45 M
Price
0.14
Change (%)
7.23%
Volume
74,386

Prostatype Genomics AB (publ) (STO-PROGEN) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
10/31/2024 1:1000 x0.001 x0.001 Reverse

Frequently Asked Questions

  • How much would Prostatype Genomics AB (publ) stock be worth if it never split?
    If Prostatype Genomics AB (publ) (stock symbol: STO-PROGEN) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-1000) that occurred on 10/31/2024.
  • Prostatype Genomics AB (publ) (stock symbol: STO-PROGEN) has undergone a total of one stock splits. The most recent split occurred on 10/31/2024. One share bought prior to the first split on 10/31/2024 would now equal 0.00 shares.
  • Prostatype Genomics AB (publ) (stock symbol: STO-PROGEN) has undergone one stock splits in its history. The most recent split, a 1-for-1000 split, occurred on 10/31/2024. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.